Back to calendar
Myriad Genetics, Inc. (MYGN) Earnings
MYGN reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.06
Actual EPS: $-0.09
EPS surprise: -32.30%
Company overview
Market Cap$581.3M
PriceUSD 6.16
EPS (TTM)-4.32
52-week high8.59
52-week low3.53
SectorHealth Technology
IndustryMedical Specialties
Employees2,700